DT
HAE icon

Diversified Trust’s Haemonetics HAE Stock Holding History

Diversified Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,596
Closed -$991K – 866
2022
Q4 		$991K Sell
12,596
-70
-0.6% -$5.63K 0.04% 240
2022
Q3 		$938K Buy
12,666
+1,071
+9% +$76.9K 0.04% 224
2022
Q2 		$756K Sell
11,595
-20
-0.2% -$1.18K 0.03% 291
2022
Q1 		$734K Sell
11,615
-222
-2% -$12.1K 0.03% 334
2021
Q4 		$628K Buy
11,837
+756
+7% +$46.1K 0.02% 382
2021
Q3 		$782K Buy
11,081
+8
+0.1% +$505 0.03% 277
2021
Q2 		$738K Buy
+11,073
New +$784K 0.03% 296
2013
Q4 		$526K Buy
12,475
+1,400
+13% +$57.6K 0.05% 318
2013
Q3 		$442K Buy
+11,075
New +$465K 0.05% 339

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversified Trust's HAE Position: Q1 2023 in Review

Diversified Trust sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 12,596 shares — an estimated $991K sold.

Diversified Trust first reported a position in HAE in Q3 2013 and held it in 9 quarters. The position peaked at $991K in Q4 2022. 300 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • Diversified Trust reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • Diversified Trust sold 12,596 Haemonetics shares in Q1 2023, an estimated $991K.
  • Diversified Trust first reported a position in Haemonetics in Q3 2013 and held it in 9 quarters.
  • Diversified Trust's Haemonetics position peaked at $991K in Q4 2022.
  • 300 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on Diversified Trust's 13F filing for Q1 2023, filed 7 Apr 2023.